A Pilot, Prospective, Open-Label Simplification Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Once-Daily Lopinavir-Ritonavir Monotherapy in HIV-HCV Coinfected Patients: The MONOCO Study-Reference-Cited by-同舟云学术

A Pilot, Prospective, Open-Label Simplification Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Once-Daily Lopinavir-Ritonavir Monotherapy in HIV-HCV Coinfected Patients: The MONOCO Study

Published:2012-08 Issue:4 Volume:13 Page:179-188
ISSN:1528-4336
Container-title:HIV Clinical Trials
language:en
Short-container-title:HIV Clinical Trials

Author:

Cooper Curtis,la Porte Charles,Tossonian Harout,Sampalis John,Ackad Nabil,Conway Brian

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases

Link

http://www.tandfonline.com/doi/pdf/10.1310/hct1304-179

Reference37 articles.

1. Mortality due to Liver Failure and Impact on Survival of Hepatitis Virus Infections in HIV-Infected Patients Receiving Potent Antiretroviral Therapy

2. Hepatotoxicity Development During Antiretroviral Therapy Containing Protease Inhibitors in Patients With HIV

3. Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection

4. Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy

5. Low Frequency of Severe Hepatotoxicity and Association With HCV Coinfection in HIV-Positive Patients Treated With HAART

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Drugs for the Treatment of COVID-19: Synthesis, Brief History and Application;Current Drug Research Reviews;2021-12-07

2. Cerebrospinal fluid and plasma lopinavir concentrations and viral response in virologically suppressed patients switching to lopinavir/ritonavir monotherapy once daily;Antiviral Therapy;2015

3. Hepatitis C virus infection in patients with HIV-1: epidemiology, natural history and management;Expert Review of Gastroenterology & Hepatology;2014-01-22

4. Durability of Lopinavir/ritonavir mono-therapy in individuals with viral load ≤50 copies/mL in the observational setting;Antiviral Therapy;2013